Financials
- Market Capitalization 9.71 B
- Employee 730
- Founded 1998
- CEO N/A
- Website www.corcept.com
- Headquarter Delaware, United States
- FIGI BBG000BKJG33
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 916 | KRYS Krystal Biotech, Inc. - Common Stock | 339.43 USD | -6.61% | -7.91% | +3.55% | +81.39% | 10.01 B USD | ||
| 925 | NUVL Nuvalent, Inc. - Class A Common Stock | 123.96 USD | +0.02% | +0.18% | +0.45% | +30.55% | 9.79 B USD | ||
| 955 | KYMR Kymera Therapeutics, Inc. - Common Stock | 112.08 USD | +1.52% | -5.91% | +30.51% | +89.64% | 9.22 B USD | ||
| 959 | PRAX Praxis Precision Medicines, Inc. - Common Stock | 327.68 USD | +4.17% | +1.30% | +23.69% | +529.19% | 9.14 B USD |
Frequently asked questions about Corcept Therapeutics Incorporated - Common Stock
What is the Corcept Therapeutics Incorporated - Common Stock stock price today?
The current price of Corcept Therapeutics Incorporated - Common Stock (CORT) is 90.47. Over the past 24 hours, the stock has changed by +5.32%. Follow the CORT chart for real-time price dynamics.
What is the stock ticker of Corcept Therapeutics Incorporated - Common Stock?
Corcept Therapeutics Incorporated - Common Stock trades under the ticker CORT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Corcept Therapeutics Incorporated - Common Stock stock going up?
CORT has changed by -2.47% over the last week, +8.76% over the last month, and +23.31% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Corcept Therapeutics Incorporated - Common Stock net income for the last quarter?
Corcept Therapeutics Incorporated - Common Stock reported net income of -31.76 M for the last quarter. The previous quarter showed 24.29 M, which means net income changed by -230.77%.
How many employees does Corcept Therapeutics Incorporated - Common Stock have?
As of the latest available data, Corcept Therapeutics Incorporated - Common Stock has 730 employees. Workforce size can provide additional context about the company's scale and operations.
What is Corcept Therapeutics Incorporated - Common Stock EBITDA?
Corcept Therapeutics Incorporated - Common Stock EBITDA is -49 M, and its EBITDA margin is -29.72%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Corcept Therapeutics Incorporated - Common Stock stock?
You can buy Corcept Therapeutics Incorporated - Common Stock (CORT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Corcept Therapeutics Incorporated - Common Stock stock?
Investing in Corcept Therapeutics Incorporated - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CORT chart and related analysis on metatrader.com as part of your research.